Industry

Findings show a significant increase in NAD+ levels and within-group benefits in fatigue, depression, and sleep quality LOS ANGELES–(BUSINESS WIRE)–$NAGE #Biotech—Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today shared promising results from the first-of-its-kind clinical trial published today in The … [Read more…]

LONDON–(BUSINESS WIRE)–#AI—LabGenius Therapeutics (“LabGenius”), a drug discovery company combining artificial intelligence (AI) and high-throughput experimentation to advance next-generation multispecific antibodies for solid tumours, today announced a scientific poster will be presented at the ESMO Immuno-Oncology Congress 2025, being held December 10 – 12, 2025, at the Queen Elizabeth II Centre in London, United Kingdom. LabGenius’ … [Read more…]

CARLSBAD, Calif.–(BUSINESS WIRE)–Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will participate in fireside chats at the following investor conferences: Stifel 2025 Healthcare Conference on Thursday, November 13, 2025 Jefferies Global Healthcare Conference on Tuesday, November 18, 2025 A live webcast of these presentations can be accessed on the Investors & Media section of … [Read more…]

LYON, France & PITTSBURGH–(BUSINESS WIRE)–#Biotech–Brenus Pharma, a clinical-stage biotechnology company developing first-in-class in vivo immunotherapies for solid tumors, announced the appointment of Olivera J. Finn, Distinguished Professor at the University of Pittsburgh School of Medicine, to its Scientific Advisory Board (SAB). This strategic addition strengthens Brenus’ international SAB as the company advances its proprietary Stimulated … [Read more…]

BAAR, Switzerland–(BUSINESS WIRE)–Novocure (NASDAQ: NVCR) announced today that management will participate in the Jefferies Global Healthcare Conference in London on Wednesday, November 19, 2025. Ashley Cordova, Chief Executive Officer, will present on behalf of the company at 2:00 p.m. GMT (9:00 a.m. ET). Ms. Cordova will be joined by Christoph Brackmann, Chief Financial Officer, for … [Read more…]

BASEL, Switzerland–(BUSINESS WIRE)–Indivi, an independent TechBio company, today announced the closing of a CHF15 million financial investment round led by Ava Investors. The additional financial resources will accelerate the validation and deployment of precision medicine tools in early-phase neuroscience drug development, targeting Alzheimer’s disease (AD). “The field of neurodegeneration remains one of the toughest challenges … [Read more…]

Transformative alliance to Create the world-leading clinical infrastructure and breakthrough biotechnology to redefine the therapeutic landscape of sepsis. TOULOUSE, France & FULLERTON, Calif.–(BUSINESS WIRE)–ABIONYX Pharma, (FR0012616852 – ABNX), a next-generation biotechnology company developing breakthrough therapies for severe and underserved diseases, today announced it has entered advanced strategic discussions with IHU SEPSIS, the world’s first and … [Read more…]

  ROCHESTER, Minn.–(BUSINESS WIRE)–Please replace the release with the following corrected version due to multiple revisions. The updated release reads: RION LAUNCHES RION VET TO TRANSFORM ANIMAL HEALTH WITH FIRST-IN-CLASS BIOLOGIC THERAPEUTIC; APPOINTS INDUSTRY LEADER MARK HERTHEL AS CEO; ANNOUNCES SERIES A FULFILLMENT RION, a clinical-stage regenerative medicine company and global leader in exosome-based therapeutics, … [Read more…]

New integration modernizes prescription workflows and enhances patient safety through partnership with ScriptSure SAN FRANCISCO–(BUSINESS WIRE)–Vagaro, the leading software for businesses in beauty, wellness, and fitness, recently announced the launch of E-Prescribe, a new integration designed to modernize and simplify how medspas and other providers manage prescriptions. Developed in partnership with ScriptSure, the feature enables … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Tendinopathy Market – A Global and Regional Analysis: Focus on Treatment and Region – Analysis and Forecast, 2025-2035” has been added to ResearchAndMarkets.com’s offering. The global tendinopathy market is experiencing notable expansion, driven by the increasing prevalence of musculoskeletal disorders, heightened awareness about the condition, and advancements in pharmacological, regenerative, and biologic therapies. … [Read more…]